Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
301 studies found for:    Lymphoma AND (women OR woman OR female)
Show Display Options
Rank Status Study
1 Unknown  Gonadal Toxicity in Women With Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Intervention:
2 Recruiting Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Conditions: Breast Cancer;   Lymphoma;   Hodgkin's Lymphoma
Interventions: Behavioral: surveys;   Other: Blood draw;   Device: Transvaginal ultrasounds
3 Completed Amifostine for Head and Neck Irradiation in Lymphoma
Conditions: Lymphoma;   Hodgkin's Disease;   Non-Hodgkin's Lymphoma
Interventions: Drug: Amifostine;   Radiation: Radiation Therapy
4 Completed Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma
Condition: Hodgkins Lymphoma
Interventions: Drug: 8 cycles BEACOPPesc plus oral contraceptive;   Drug: 8 cycles BEACOPPesc plus Goserelin
5 Not yet recruiting Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.
Conditions: Lymphoma;   Autonomic Imbalance;   Cancer Survivorship
Interventions: Drug: Ivabradine;   Drug: Placebo Oral Tablet
6 Not yet recruiting Retrospective Analysis of Lymphomas and Cancers Synchronous Occurrence in Picardy From 2007 to 2012
Conditions: Lymphoma;   Cancer
Intervention: Other: Show an increase in incidence of cancers in patients with synchronous lymphoma
7 Completed Treatment of Follicular Lymphoma With High Dose Therapy and Stem Cell Support Followed by Rituximab and Alpha Interferon
Condition: Follicular Lymphoma
Interventions: Drug: Rituximab;   Drug: Alpha Interferon
8 Recruiting Lymphoma Bridge Transplant Study
Conditions: Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma
Interventions: Drug: Bendamustine;   Drug: Carmustine;   Drug: Etoposide;   Drug: Melphalan;   Drug: Cytarabine;   Drug: Alemtuzumab;   Biological: Autologous Stem Cell Transplantation;   Biological: Allogeneic Stem Cell Transplantation;   Drug: Rituximab
9 Completed Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: pegfilgrastim;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate;   Other: pharmacological study;   Radiation: radiation therapy
10 Active, not recruiting Helical Irradiation of Total Skin (HITS) for Cutaneous Lymphoma
Condition: Cutaneous T-cell Lymphoma
Intervention: Radiation: HITS
11 Terminated Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy
Condition: Breast Cancer
Interventions: Procedure: Breast MRI;   Procedure: Mammogram
12 Recruiting A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
Conditions: Solid Cancers;   Non-Hodgkin's Lymphoma
Interventions: Drug: Fulvestrant;   Drug: GDC-0032;   Drug: Letrozole;   Drug: Midazolam
13 Suspended Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Dose-Adjusted-Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (DA-TEDDI-R) in Primary CNS Lymphoma
Condition: Primary Central Nervious System Lymphoma
Interventions: Drug: TEDDI;   Biological: Rituximab;   Drug: Cytarabine;   Drug: TEDD;   Drug: Ibrutinib
14 Not yet recruiting Cyclophosphamide and Alemtuzumab In Lymphoma
Conditions: Non Hodgkin Lymphoma;   High-grade B-cell Lymphoma;   CD52 Positive Non-Hodgkin Lymphoma;   DLBCL or High-grade B-cell Lymphoma NOS
Interventions: Drug: Cyclophosphamide;   Drug: Alemtuzumab
15 Enrolling by invitation Helical Irradiation of Total Skin (HITS) for T Cell Lymphoma
Condition: T-cell Lymphoma
Intervention:
16 Terminated
Has Results
CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma
Condition: T-cell Non-Hodgkin Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Etoposide;   Drug: Prednisone;   Drug: Filgrastim;   Drug: Plerixafor;   Procedure: Stem Cell Collection;   Drug: Palifermin;   Drug: Gemcitabine;   Drug: Busulfan;   Drug: Melphalan;   Procedure: Stem Cell Transplant
17 Recruiting T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas
Conditions: Lymphoma, Large-Cell, Anaplasitc;   Hodgkin Disease;   Lymphoma, Hodgkins;   Enteropathy-Associated T-Cell Lymphoma;   Lymphoma, Extranodal NK-T-Cell
Interventions: Biological: Anti-CD30-CAR T cells;   Drug: Cyclophosphamide;   Drug: Fludarabine
18 Completed Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1
Condition: Human T-Lymphoma Virus Type I
Intervention:
19 Completed Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: Rituxan;   Drug: 1018 ISS
20 Recruiting A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
Condition: Hepatosplenic T-Cell Lymphoma
Intervention: Biological: Collection of samples

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.